DanCann Pharma A/S (NGM:DANCAN)
0.444
-0.008 (-1.77%)
At close: Dec 4, 2025
DanCann Pharma Cash Flow Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -9.98 | -8.35 | -62.26 | -16.06 | -11.75 | -4.26 | Upgrade
|
| Depreciation & Amortization | 1.99 | 2.03 | 3.38 | 2.23 | 0.89 | 0.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 43.84 | - | - | - | Upgrade
|
| Other Operating Activities | 1.25 | 1.13 | 1.49 | 3.24 | -3.21 | -1.71 | Upgrade
|
| Change in Accounts Receivable | 2.32 | 0.16 | 2.88 | -0.14 | 1.78 | -4.87 | Upgrade
|
| Change in Inventory | 0.06 | 0.01 | 0 | -0.07 | -0.04 | -0.01 | Upgrade
|
| Change in Other Net Operating Assets | 1.35 | -0.21 | -1.37 | -0.92 | 0.34 | 3.08 | Upgrade
|
| Operating Cash Flow | -3.01 | -5.24 | -12.04 | -11.73 | -11.99 | -7.66 | Upgrade
|
| Capital Expenditures | - | - | -0.01 | -1.01 | -6.37 | -4.01 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.16 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -4.03 | -7.26 | -26.03 | -14.74 | Upgrade
|
| Other Investing Activities | - | - | - | - | - | -0.32 | Upgrade
|
| Investing Cash Flow | -0.04 | - | -4.04 | -8.27 | -32.25 | -19.07 | Upgrade
|
| Long-Term Debt Issued | - | - | 6.21 | 5.07 | 10.18 | 0.19 | Upgrade
|
| Total Debt Issued | - | - | 6.21 | 5.07 | 10.18 | 0.19 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -0.55 | Upgrade
|
| Long-Term Debt Repaid | - | - | -3.22 | -7.54 | -0.33 | -0.96 | Upgrade
|
| Total Debt Repaid | - | - | -3.22 | -7.54 | -0.33 | -1.5 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | 3 | -2.47 | 9.84 | -1.32 | Upgrade
|
| Issuance of Common Stock | 0.2 | 11.84 | 5.6 | 31.23 | 21.46 | 53.88 | Upgrade
|
| Other Financing Activities | -0.03 | -5.14 | -1.27 | -5.74 | -0.67 | -4.67 | Upgrade
|
| Financing Cash Flow | 0.17 | 6.7 | 7.33 | 23.01 | 30.64 | 47.89 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | - | Upgrade
|
| Net Cash Flow | -2.88 | 1.47 | -8.75 | 3.02 | -13.6 | 21.15 | Upgrade
|
| Free Cash Flow | -3.01 | -5.24 | -12.04 | -12.74 | -18.36 | -11.68 | Upgrade
|
| Free Cash Flow Margin | -75.09% | -71.03% | -168.35% | -177.16% | -796.31% | - | Upgrade
|
| Free Cash Flow Per Share | -0.52 | -1.31 | -85.03 | -195.89 | -812.31 | - | Upgrade
|
| Cash Income Tax Paid | - | - | -1.47 | -5.42 | -0.21 | - | Upgrade
|
| Levered Free Cash Flow | 0.04 | -3.32 | -36.68 | -25.14 | -32.07 | -28.78 | Upgrade
|
| Unlevered Free Cash Flow | 0.3 | -2.49 | -35.22 | -23.25 | -31.29 | -28.69 | Upgrade
|
| Change in Working Capital | 3.73 | -0.04 | 1.51 | -1.13 | 2.09 | -1.79 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.